Immediate Impact
33 standout
Citing Papers
PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
2024 Standout
The emerging role of lactate in tumor microenvironment and its clinical relevance
2024 Standout
Works of Brian Hinds being referenced
Dual MEK/AKT inhibition with trametinib and GSK 2141795 does not yield clinical benefit in metastatic NRAS ‐mutant and wild‐type melanoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Brian Hinds | 86 | 83 | 37 | 64 | 47 | 291 | |
| Raegan Hunt | 107 | 61 | 57 | 44 | 46 | 301 | |
| X. Soria | 110 | 53 | 84 | 65 | 45 | 307 | |
| Daifullah Al Aboud | 57 | 32 | 47 | 67 | 38 | 304 | |
| P. Schoenlaub | 93 | 126 | 59 | 25 | 26 | 243 | |
| Sarla Agarwal | 42 | 65 | 51 | 47 | 35 | 330 | |
| Sheetanshu Kumar | 68 | 54 | 46 | 21 | 45 | 236 | |
| R André | 55 | 42 | 27 | 30 | 62 | 250 | |
| Alin Codruț Nicolescu | 126 | 67 | 46 | 39 | 45 | 330 | |
| A. Nuño‐González | 147 | 39 | 101 | 24 | 32 | 310 | |
| B. Crickx | 79 | 35 | 51 | 25 | 49 | 316 |
All Works
Loading papers...